Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Core Insights - Ozempic has emerged as a leading weight loss drug, generating significant sales and market interest [1] Company Summary - Novo Nordisk A/S, the manufacturer of Ozempic, is projected to achieve sales of $17 billion in 2024 and up to $25 billion in 2025, indicating strong growth potential [1]